Clinical practice guideline on asthma (part I);Guía de práctica clínica sobre asma (1a parte)

Anales de Pediatria

Volumn 64, Issue 6, 2006, Pages 557-572

  Merino Hernandez M ^a,a   Aranguren Castro, J ^b   Callen Blecua M ^c,m   Elorz Lambarri, J ^d   Etxeberria Agirre, A ^e   Galdiz Iturri, J B ^d   Irizar Aranburu I ^f   Lekue Alkorta, I ^e   Lizarraga Azparren, M A ^g   Maeztu Lopez De Alda M ^b   Marques Gonzalez Ma L ^h   Martinez Gonzalez A ⁱ   Merino Nazabal J M ^j   Rotaeche Del Campo, R ^k   Villar Alvarez M ^l  

^a HOSPITAL DONOSTIA   (Spain)

^b Centro de Salud Lutxana   (Spain)

^c Centro de Salud Bidebieta   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e Hospital de Cruces ^*

^f Centro de Salud Idiazabal   (Spain)

^g Centro de Salud Erandio   (Spain)

^h Centro de Salud de Leioa   (Spain)

ⁱ Centro de Salud La Paz   (Spain)

^j Centro de Salud Leioa   (Spain)

^k Centro de Salud Alza   (Spain)

^l HOSPITAL DE BASURTO   (Spain)

^m NONE   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGIC ASTHMA; ASTHMA; ATOPY; BRONCHODILATATION; CHILD CARE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EXERCISE; FAMILY HISTORY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; PRACTICE GUIDELINE; PREVALENCE; PRIMARY PREVENTION; PROVOCATION TEST; REVIEW; SECONDARY PREVENTION; SPIROMETRY;

EID: 33746547260     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13089921     Document Type: Article

References (75)

1. Aguinaga OI, Arnedo PA, Bellido J, Guillen GF, Suárez Varela MM. Prevalencia de síntomas relacionados con el asma en ninos de 13-14 años de 9 poblaciones españolas. Grupo Español del Estudio ISAAC (International Study of Asthma and Allergies in Childhood). Med Clin (Barc). 1999;112:171-5.
2. Políticas de Salud para Euskadi: Plan de Salud 2002-2010. Departamento de Sanidad. Gobierno Vasco, ed. Vitoria-Gasteiz. Servicio Central De Publicaciones del Gobierno Vasco. 2002.
3. Grupo Español para el Manejo del Asma (GEMA). Guía Española para el Manejo del Asma. Arch Bronconeumol. 2003;39 Supl 5:1-42.
4. García-Marcos L, Quirós AB, Hernández GG, Guillén-Grima F, Díaz CG, Urena IC, et al. Stabilization of asthma prevalence among adolescents and increase among schoolchildren (ISAAC phases I and III) in Spain. Allergy. 2004;59:1301-7.
5. García de Andoin N, Miner I, Gómez Cabanillas P, Pérez-Yarza EG. Prevalencia y gravedad de síntomas relacionados con asma en Guipúzcoa. Resultados del estudio ISAAC-3b. Poster 53 Congreso de la Asociación Española de Pediatría Madrid, 17-19 junio 2004.
6. Callén M, Alústiza E, Solórzano C, Aizpúrua P, Mancisidor L, Iglesias P. Prevalencia de Asma y factores de riesgo de asma en Guipúzcoa: estudio multicéntrico caso-control. An Esp Pediatr. 1995;43:347-50.
7. Base de datos del Instituto Nacional de Estadística, 2005. Disponible en: cgi/um?L = 0
8. Memoria del trabajo Evaluación de la prescripción en el asma y en la enfermedad pulmonar obstructiva crónica en seis centros de salud con historia clínica informatizada. Comarca Gipuzkoa Este. Osakidetza-Servicio Vasco de Salud, editor. 2000.
9. Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96:142-9.
10. Guía de Práctica Clínica de Asma. Comarca Gipuzkoa Este. Osakidetza-Servicio Vasco de Salud, editor. 1999.
11. British guideline on the management of asthma. Thorax. 2003;58 Suppl 1:i1-i94.
12. New Zealand Guidelines Group. The diagnosis and treatment of adult asthma. 2002. Disponible en: http://www.nzgg.org.nz/library.cfm [Acceso en julio de 2004].
13. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8:iii-72.
14. Etxeberria A, Rotaeche R, Lekue I, Callén M, Merino M, Villar M, et al. Descripción de la metodología de elaboración- adaptación-actualización empleada en la guía de práctica clínica sobre asma de la CAPV. Proyecto de Investigación Comisionada. Vitoria-Gasteiz. Departamento de Sanidad. Gobierno Vasco, 2005. Informe no. D-05-03.
15. Oxman AD, Sackett DL, Guyatt GH. Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA. 1993;270:2093-5.
16. The AGREE Collaboration. AGREE Instrument Spanish Version. Disponible en: http://www.agrecollaboration.org [Acceso en julio de 2004].
17. Scottish Intercollegiate Guidelines Group. A guideline developers' handbook. Edinburgh, SIGN Publication No. 50. 2001.
18. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Disponible en: http://www.ginasthma.com/ [Acceso en julio de 2004].
19. British guideline on the management of asthma. A national clinical guideline. Revisted edition April 2004. Edinburgh.
20. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332:133-8.
21. Siersted HC, Boldsen J, Hansen HS, Mostgaard G, Hyldebrandt N. Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study. BMJ. 1998;316:651-5.
22. Hall CB, Wakefield D, Rowe TM, Carlisle PS, Cloutier MM. Diagnosing pediatric asthma: Validating the Easy Breathing Survey. J Pediatr. 2001;139:267-72.
23. (Eur Respir J. 1989;2:940-5.)
24. Burke W, Fesinmeyer M, Reed K, Hampson L, Carlsten C. Family history as a predictor of asthma risk. Am J Prev Med. 2003;24:160-9.
25. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax. 1999;54:268-72.
26. Guerra S, Sherrill DL, Martínez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109:419-25.
27. Illi S, Von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2001;113:925-31.
28. Arshad SH, Kurukulaaratchy RJ, Fenn M, Matthews S. Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest. 2005;127:502-8.
29. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its association with allergic disorders at age 4 years: A whole population birth cohort study. Pediatrics. 2001;108:E33.
30. Kulig M, Bergmann R, Tacke U, Wahn U, Guggenmoos-Holzmann I. Long-lasting sensitization to food during the first two years precedes allergic airway disease. The MAS Study Group, Germany. Pediatr Allergy Immunol. 1998;9:61-7.
31. Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol. 1999;103:1173-9.
32. Sasai K, Furukawa S, Muto T, Baba M, Yabuta K, Fukuwatari Y. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease. J Pediatr. 1996;128:834-40.
33. Tariq SM, Matthews SM, Hakim EA, Arshad SH. Egg allergy in infancy predicts respiratory allergic disease by 4 years of age. Pediatr Allergy Immunol. 2000;11:162-7.
34. Kotaniemi-Syrjanen A, Reijonen TM, Romppanen J, Korhonen K, Savolainen K, Korppi M. Allergen-specific immunoglobulin E antibodies in wheezing infants: The risk for asthma in later childhood. Pediatrics. 2003;111:e255-e61.
35. Rhodes HL, Sporik R, Thomas P, Holgate ST, Cogswell JJ. Early life risk factors for adult asthma: A birth cohort study of subjects at risk. J Allergy Clin Immunol. 2001;108:720-5.
36. Castro-Rodríguez JA, Holberg CJ, Wright AL, Martínez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-6.
37. Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH. Predicting persistent disease among children who wheeze during early life. Eur Respir J. 2003;22:767-71.
38. Guilbert TW, Morgan WJ, Krawiec M, Lemanske RF Jr, Sorkness C, Szefler SJ, et al. The Prevention of Early Asthma in Kids study: Design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin Trials. 2004;25:286-310.
39. McGin T, Guyatt G. Diagnosis. Clinical prediction Rules. En: American Medical Association, ed. User's Guides to the Medical Literature. A manual for evidence-based clinical practice; 2002.
40. Den Otter JJ, Reijnen GM, Van den Bosch WJ, Van Schayck CP, Molema J, Van Weel C. Testing bronchial hyper-responsiveness: Provocation or peak expiratory flow variability? Br J Gen Pract. 1997;47:487-92.
41. 1 responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest. 2001;119:1001-10.
42. Popovic-Grle S, Mehulic M, Pavicic F, Babic I, Beg-Zec Z. Clinical validation of bronchial hyperresponsiveness, allergy tests and lung function in the diagnosis of asthma in persons with dyspnea. Coll Antropol. 2002;26 Suppl:119-27.
43. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, et al. Diagnosing asthma: Comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004;169:473-8.
44. Lung function testing: Selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144:1202-18.
45. Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M. In search of childhood asthma: Questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax. 2002;57:120-6.
46. Selective Chest Radiography. Health Services Utilization and Research Comission (HSRUC), editor. 2000. Health Services Utilization and Research Committee (HSRUC).
47. National Asthma Council Australia (NAC). Asthma Management Handbook, 2002. Disponible en: http://www.nationalasthma.org.au/publications/amh/amhcont. htm
48. National Institutes of Health. National Asthma Education and Prevention Program Expert Report 2 (NAEP EPR-2). Guidelines for the Dagnosis and Management of Asthma. Update on selected topics, 2002.
49. Institute for Clinical systems Improvement (ICSI). Diagnosis and management of asthma. Bloomington (MN). Institute for Clinical Systems Improvement (ICSI), 2003.
50. Singapore Ministry of Health. Management of asthma, 2002. 22-2-2003. Disponible en: http://www.moh.gov.sg/cmaweb/attachments/publication/asthma.pdf
51. National Institutes of Health. National Asthma Education and Prevention Program Expert Report 2 (NAEP EPR-2). Guidelines for the Diagnosis and Management of Asthma, 1997.
52. Colice GL. Categorizing Asthma Severity: An Overview of National Guidelines. Clin Med Res. 2004;2:155-63.
53. O'Byrne PM, Barnes PJ, Rodríguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392-7.
54. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: A randomized, double-blind trial. Lancet. 2003;361:1071-6.
55. Bacharier LB, Strunk RC, Mauger D, White D, Lemanske RF Jr, Sorkness CA. Classifying asthma severity in children: Mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med. 2004;170:426-32.
56. Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma in childhood: A systematic review with meta-analysis of prospective studies. J Pediatr. 2001;139:261-6.
57. Chulada PC, Arbes SJ Jr, Dunson D, Zeldin DC. Breast-feeding and the prevalence of asthma and wheeze in children: Analyses from the Third National Health and Nutrition Examination Survey, 1988-1994. J Allergy Clin Immunol. 2003;111:328-36.
58. Kull I, Wickman M, Lilja G, Nordvall SL, Pershagen G. Breast feeding and allergic diseases in infants-a prospective birth cohort study. Arch Dis Child. 2002;87:478-81.
59. Wright AL, Holberg CJ, Taussig LM, Martínez FD. Factors influencing the relation of infant feeding to asthma and recurrent wheeze in childhood. Thorax. 2001;56:192-7.
60. Sears MR, Greene JM, Willan AR, Taylor DR, Flannery EM, Cowan JO, et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: A longitudinal study. Lancet. 2002;360:901-7.
61. Cook DG, Strachan DP. Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax. 1999;54:357-66.
62. Jaakkola JJ, Jaakkola MS. Effects of environmental tobacco smoke on the respiratory health of children. Scand J Work Environ Health. 2002;28 Suppl 2:71-83.
63. Ponsonby AL, Couper D, Dwyer T, Carmichael A, Kemp A, Cochrane J. The relation between infant indoor environment and subsequent asthma. Epidemiology. 2000;11:128-35.
64. Gilliland FD, Li YF, Dubeau L, Berhane K, Avol E, McConnell R, et al. Effects of glutathione Stransferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med. 2002;166:457-63.
65. Jaakkola JJ, Nafstad P, Magnus P. Environmental tobacco smoke, parental atopy, and childhood asthma. Environ Health Perspect. 2001;109:579-82.
66. Becker A, Watson W, Ferguson A, Dimich-Ward H, Chan-Yeung M. The Canadian asthma primary prevention study: Outcomes at 2 years of age. J Allergy Clin Immunol. 2004;113:650-6.
67. Jaakkola MS, Jaakkola JJ. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health. 2002;28 Suppl 2:52-70.
68. Morgan WJ, Crain EF, Gruchalla RS, O'Connor GT, Kattan M, Evans R III, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004;351:1068-80.
69. Wilson SR, Yamada EG, Sudhakar R, Roberto L, Mannino D, Mejía C, et al. A controlled trial of an environmental tobacco smoke reduction intervention in low-income children with asthma. Chest. 2001;120:1709-22.
70. Gotzsche PC, Johansen HK, Schmidt LM, Burr ML. House dust mite control measures for asthma. Cochrane Database Syst Rev. 2004;(4):CD001187.
71. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434.
72. Short JA, Barr CA, Palmer CD, Goddard JM, Stack CG, Primhak RA. Use of diclofenac in children with asthma. Anaesthesia. 2000;55:334-7.
73. Lesko SM, Louik C, Vezina RM, Mitchell AA. Asthma morbidity after the short-term use of ibuprofen in children. Pediatrics. 2002;109(2):E20.
74. Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev. 2004;(2):CD000364.
75. Bueving HJ, Bernsen RM, De Jongste JC, Suijlekom-Smit LW, Rimmelzwaan GF, Osterhaus AD, et al. Influenza vaccination in children with asthma: Randomized double-blind placebo controlled trial. Am J Respir Crit Care Med. 2004;169:488-93.